Scarica l'app Stockscreener
5.833
12.39%
0.643
Precedente Chiudi:
$5.19
Aprire:
$5.49
Volume 24 ore:
21,869
Relative Volume:
3.14
Capitalizzazione di mercato:
$96.78M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+9.61%
1M Prestazione:
+0.92%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$5.49
$5.90
Intervallo di 1 settimana:
$5.01
$5.90
Portata 52W:
$4.7237
$6.85
Bioharvest Sciences Inc Stock (BHST) Company Profile
Nome
Bioharvest Sciences Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta BHST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BHST
Bioharvest Sciences Inc
|
5.85 | 96.78M | 0 | 0 | 0 | 0.00 |
|
KHC
Kraft Heinz Co
|
30.27 | 36.98B | 25.85B | 2.74B | 3.02B | 2.26 |
|
GIS
General Mills Inc
|
59.70 | 33.00B | 19.90B | 2.60B | 2.80B | 4.60 |
|
K
Kellanova
|
82.28 | 28.11B | 12.75B | 1.34B | 1.13B | 3.87 |
|
MKC
Mccormick Co Inc
|
80.66 | 21.49B | 6.68B | 792.60M | 774.40M | 2.94 |
|
HRL
Hormel Foods Corp
|
29.57 | 16.31B | 11.92B | 805.04M | 1.01B | 1.46 |
Bioharvest Sciences Inc Stock (BHST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-18 | Iniziato | Maxim Group | Buy |
Bioharvest Sciences Inc Borsa (BHST) Ultime notizie
BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025 - Newsfile
BioHarvest Sciences achieves breakthrough in Liver health with Olive Cell compound - Proactive Investors USA
BioHarvest’s Olive Cell Compound Shows Promise in Tackling Liver Fat Accumulation - TipRanks
BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells - Newsfile
EXCLUSIVE: Botanical Synthesis Tech-Focused BioHarvest's First Synthetic Olive Cells Shows Reduced Fat Accumulation in Liver Cells - Benzinga
BioHarvest Sciences Inc. (NASDAQ:BHST) Not Flying Under The Radar - Simply Wall St
BioHarvest Sciences Inc.'s (NASDAQ:BHST) Shift From Loss To Profit - Yahoo Finance
BioHarvest Sciences surpasses 50 million dollars in VINIA sales, plans major production expansion - Proactive Investors USA
BioHarvest's VINIA sales top $50M, plans production boost By Investing.com - Investing.com Canada
BioHarvest’s VINIA Achieves $50 Million in Sales, Plans Major Expansion - TipRanks
BioHarvest's VINIA sales top $50M, plans production boost - Investing.com India
BioHarvest’s VINIA sales top $50M, plans production boost - Investing.com
BioHarvest’s VINIA sales top $50M, plans production boost By Investing.com - Investing.com Nigeria
BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD - Newsfile
BioHarvest Sciences to Delist from CSE, Focuses on Nasdaq - TipRanks
CSE Bulletin: DelistBioHarvest Sciences Inc. (BHSC) - TradingView
BioHarvest CEO to present at WeBull Consumer Stocks Virtual Webinar - Proactive Investors USA
BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar - TipRanks
BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar on February 18 - Newsfile
Exclusive: Inside BioHarvest's Revolutionary Plant-Based TechnologyCEO Reveals Growth Strategy - StockTitan
Bioharvest Sciences to voluntarily delist from CSE - Proactive Investors Australia
BioHarvest Sciences to Delist from CSE, Focus on Nasdaq - TipRanks
When Will BioHarvest Sciences Inc. (CSE:BHSC) Become Profitable? - Simply Wall St
BioHarvest Sciences reports material change - Investing.com India
BioHarvest Sciences Appoints Sharon Malka to Board of Directors - TipRanks
BioHarvest Sciences reports material change By Investing.com - Investing.com UK
BioHarvest Sciences appoints veteran technology leader to board of directors - Proactive Investors UK
BioHarvest Announces Appointment of Sharon Malka to Board of Directors - Newsfile
Bioharvest Sciences Inc. Appoints Sharon Malka as Independent Director -January 22, 2025 at 08:34 am EST - Marketscreener.com
OTC Markets Group Announces Quarterly Index Performance and Rebalancing - GlobeNewswire Inc.
BioHarvest Sciences positioned for ‘legacy year’ in 2025, building on momentum with new innovations and strategic collaborations - Proactive Investors UK
BioHarvest Sciences doubles VINIA business, eyes growth By Investing.com - Investing.com Australia
CSE Bulletin: NV Issuer DesignationBioHarvest Sciences Inc. (BHSC) - Newsfile
BioHarvest Sciences CEO reflects on transformative 2024, outlines vision for future growth - Proactive Investors UK
BioHarvest Sciences Unveils Strategic Growth Initiatives with New CDMO Division - TipRanks
BioHarvest Sciences doubles VINIA business, eyes growth - Investing.com
BioHarvest Issues Shareholder Letter and Provides Corporate Update - Yahoo Finance
BioHarvest Sciences (NASDAQ:BHST) Earns Buy Rating from Analysts at Maxim Group - Defense World
Maxim Group sets Buy rating on BioHarvest Sciences shares, cites robust growth - Investing.com India
Bioharvest Sciences Inc Azioni (BHST) Dati Finanziari
Non sono disponibili dati finanziari per Bioharvest Sciences Inc (BHST). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.39%
0.20%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):